Generics

The Food and Drug Administration originally approved Cyltezo in 2017 for the treatment of multiple chronic inflammatory diseases and this latest approval designates it as interchangeable across all of these indications.

The BiCNU brand and generic had a market value of approximately $19.4 million for the most recent 12 months ended August 2021, according to IQVIA.

Micafungin for injection had a market value of $132 million in the 12 months ended August 2021, according to IQVIA.

Zydus Cadila's generic Epiduo Forte provides a treatment for acne.

Dan Leonard is celebrating his first year as president and CEO of the Association for Accessible Medicines.

Amato will lead the business development of the company's generics division.

Brexpiprazole tablets had a market value of roughly $1.3 billion, according to IQVIA data from July 2021.

Christine Simmon, who also serves as executive director of the Biosimilars Council, has been with the Association for Accessible Medicines for 13 years.